All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia.
about
Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signalingChemosensitivity enhancement toward arsenic trioxide by inhibition of histone deacetylase in NB4 cell line.Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.Analyzing the Impact of Pan- and Class-Specific HDACi on Differentiation-Associated Factors.All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells.The novel three-way variant t(6;17;15)(p21;q21;q22) in acute promyelocytic leukemia with an FLT3-ITD mutation: A case report
P2860
All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia.
@en
type
label
All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia.
@en
prefLabel
All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia.
@en
P2093
P2860
P50
P356
P1476
All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia
@en
P2093
Francesca Vendemini
Pietro Gasperini
Riccardo Masetti
P2860
P304
P356
10.1586/ERA.12.101
P577
2012-09-01T00:00:00Z